Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Finance Watch: VC Deals Keep Up Fast Pace With $1.1bn In Less Than Three Weeks

Thu, 01/17/2019 - 3:21pm

Finance Watch has noted $1.1bn worth of venture capital deals so far in 2019. Meanwhile, public offerings continue to be...

      Related Stories 

Spectrum Reshuffles Focus, Selling Seven Products To Aurobindo

Thu, 01/17/2019 - 12:31pm

By selling seven approved oncology/hematology products to a US affiliate of Aurobindo, Spectrum gets cash to increase focus on late-stage...

      Related Stories 

Lilly/Loxo Deal Came Together Quickly

Thu, 01/17/2019 - 11:15am

Lilly's $8bn acquisition of genetics-based cancer specialist Loxo Oncology didn't involve any other bidders and was finalized in just days...

      Related Stories 

J&J’s Erleada Gives Chase To Xtandi For Non-Metastatic Prostate Cancer With Approval In Europe

Thu, 01/17/2019 - 8:27am

Astellas/Pfizer’s Xtandi and Johnson & Johnson’s Erleada are both now approved for non-metastatic castration-resistant prostate cancer in Europe, while Xtandi...

      Related Stories 

Aptinyx Says DPN Setback Just A Step In Seeking Chronic Pain Indication

Wed, 01/16/2019 - 1:37pm

Investors reacted negatively when Aptinyx’s lead candidate missed its primary endpoint in diabetic peripheral neuropathy, but CEO Riedel tries to...

      Related Stories 

Novartis R&D Chief Tsai On 2019 Goals, Priorities, BD And Digital Advances

Wed, 01/16/2019 - 12:32pm

R&D head John Tsai spoke with Scrip about culture change at Novartis as it moves toward advanced therapy platforms and...

      Related Stories 

Can Vivus Get Away Without Outcomes Study Of Obesity Drug Qsymia?

Tue, 01/15/2019 - 3:26pm

Fixed-dose combination of phentermine and topiramate is FDA-approved for chronic, long-term use, but the average duration in the real world...

      Related Stories 

How Lilly Aims To Make Sure Good Drugs Don't Get Lost In Translation

Tue, 01/15/2019 - 1:50pm

SVP/CSO Daniel Skovronsky says the company has invested in technology and biotech-like teams to speed up the process of translating...

      Related Stories 

The Gene Therapies Are Coming – And So Are New Ways To Pay For Them

Tue, 01/15/2019 - 12:16pm

Annual payment plans for gene therapies appear closer to becoming reality now that bluebird bio detailed plans at J.P. Morgan...

      Related Stories